Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TO0E
|
||||
| Former ID |
DNC014085
|
||||
| Drug Name |
SN-28
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531165] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C24H24N2O
|
||||
| Canonical SMILES |
CN1CCC23CC4=NC5=CC=CC=C5C=C4CC2C1CC6=C3C=C(C=C6)O
|
||||
| InChI |
1S/C24H24N2O/c1-26-9-8-24-14-22-17(10-16-4-2-3-5-21(16)25-22)11-20(24)23(26)12-15-6-7-18(27)13-19(15)24/h2-7,10,13,20,23,27H,8-9,11-12,14H2,1H3
|
||||
| InChIKey |
HDRKKGULQPRYBL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [531165] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [531165] | ||
| Kappa-type opioid receptor | Target Info | Inhibitor | [531165] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.